Dr Caroline Wilson

PhD, MRCP

School of Medicine and Population Health

Honorary Clinical Senior Lecturer

Dr Caroline Wilson
Dr Caroline Wilson
Profile picture of Dr Caroline Wilson
c.wilson@sheffield.ac.uk
The Medical School

Full contact details

Dr Caroline Wilson
School of Medicine and Population Health
The Medical School
Beech Hill Road
Sheffield
S10 2RX
Profile

For enquiries, please contact - SMPH-West-Operational@sheffield.ac.uk

Caroline graduated with distinction from Sheffield Medical School in 2002 and subsequently completed her junior doctor training in Sheffield, Australia and New Zealand. She began her higher specialist training in Medical Oncology in 2007 and in 2011 she took time out of her clinical training to carry out her PhD in Sheffield Medical School, focusing on the influence of hormones on breast cancer in the bone microenvironment.

After completing her PhD she was appointed as a consultant at Weston Park Cancer Hospital where she specialises in the treatment of breast cancer. Her research time is funded by Sheffield Teaching Hospitals NHS Foundation Trust and focuses on new therapies and therapeutic combinations for breast cancer and breast cancer bone metastases including immune-therapy. She has been primary author and co-author on multiple papers on breast cancer, bisphosphonates and bone metastases published in journals including the Lancet Oncology, Annals of Oncology, Clinical Cancer Research, JAMA oncology. She is also a reviewer for several journals.

Publications

Show: Featured publications All publications

Journal articles

  • Lee RJ, Wysocki O, Bhogal T, Shotton R, Tivey A, Angelakas A, Aung T, Banfill K, Baxter M, Boyce H , Brearton G et al (2021) . ESMO Open, 6(1).
  • George CN, Canuas-Landero V, Theodoulou E, Muthana M, Wilson C & Ottewell P (2020) . Journal of Bone Oncology, 25.
  • Wilson C, Martin C & Winter MC (2019) . Journal of Bone Oncology, 15, 100226-100226.
  • Wilson C, Bell R, Hinsley S, Marshall H, Brown J, Cameron D, Dodwell D & Coleman R (2018) . European Journal of Cancer, 94, 70-78.
  • Wilson C, Hinsley S, Marshall H, Cameron D, Bell R, Dodwell D & Coleman RE (2017) . Journal of Bone Oncology, 9, 48-54.
  • Wilson C & Coleman R (2016) . JAMA Oncology, 2(4), 423-423.
  • Wilson C, Gossiel F, Leonard R, Anderson RA, Adamson DJA, Thomas G & Coleman RE (2016) . Journal of Bone Oncology, 5(1), 43-49.
  • Hadji P, Coleman RE, Wilson C, Powles TJ, Clézardin P, Aapro M, Costa L, Body J-J, Markopoulos C, Santini D , Diel I et al (2016) . Annals of Oncology, 27(3), 379-390.
  • Wilson C, Ottewell P, Coleman RE & Holen I (2015) . BMC Cancer, 15.
  • Coleman R, Cameron D, Dodwell D, Bell R, Wilson C, Rathbone E, Keane M, Gil M, Burkinshaw R, Grieve R , Barrett-Lee P et al (2014) . The Lancet Oncology, 15(9), 997-1006.
  • Winter MC, Wilson C, Syddall SP, Cross SS, Evans A, Ingram CE, Jolley IJ, Hatton MQ, Freeman JV, Mori S , Holen I et al (2013) . Clinical Cancer Research, 19(10), 2755-2765.
  • Wilson C, Holen I & Coleman RE (2012) . Cancer Treatment Reviews, 38(7), 877-889.

Book chapters

  • Wilson C, Taylor FG & Coleman RE (2013) , Side Effects of Medical Cancer Therapy (pp. 531-567). Springer London

All publications

Journal articles

  • Saleh L, Ottewell PD, Brown JE, Wood SL, Brown NJ, Wilson C, Park C, Ali S & Holen I (2023) . Cancers, 15(8).
  • Saxton JM & Wilson C (2023) . Proceedings of the Nutrition Society, 82(1), 63-68.
  • Saxton JM, Pickering K, Wane S, Humphreys H, Crank H, Anderson AS, Cain H, Cohen J, Copeland RJ, Gray J , Hargreaves J et al (2022) . BMC Cancer, 22(1).
  • JM S, K P, S W, H C, AS A, H C, J C, RJ C, J G, J H , RJQ M et al (2022) . BMC Cancer, 22(1).
  • Kwan A, Howard F, Winder N, Atkinson E, Jailani A, Patel PB, Allen R, Ottewell PD, Shaw GC, Conner J , Wilson C et al (2022) . Future Pharmacology, 2(4), 444-459.
  • Wysocki O, Zhou C, Rogado J, Huddar P, Shotton R, Tivey A, Albiges L, Angelakas A, Arnold D, Aung T , Banfill K et al (2022) . Cancers, 14(16).
  • Winter M, Coleman R, Kendall J, Palmieri C, Twelves C, Howell S, MacPherson I, Wilson C, Purohit K, Gath J , Taylor C et al (2022) . JOURNAL OF BONE ONCOLOGY, 35.
  • Lee RJ, Wysocki O, Zhou C, Shotton R, Tivey A, Lever L, Woodcock J, Albiges L, Angelakas A, Arnold D , Aung T et al (2022) . JCO Clinical Cancer Informatics(6).
  • Boyce H, Rickards H & Wilson C (2022) . Clinical Oncology, 34, e6-e7.
  • El Badri S, Tahir B, Balachandran K, Bezecny P, Britton F, Davies M, Desouza K, Dixon S, Hills D, Moe M , Pigott T et al (2021) . The Breast, 60, 199-205.
  • Saleh L, Wilson C & Holen I (2021) . MedComm, 2(4), 514-530.
  • Porter I, Theodoulou E, Holen I, Harper-Wynne C, Baron-Hay S, Wilson C & Brown J (2021) . Journal of Bone Oncology, 31, 100402-100402.
  • Canuas-Landero VG, George CN, Lefley DV, Corness H, Muthana M, Wilson C & Ottewell PD (2021) . Frontiers in Endocrinology, 12.
  • El Badri S, Tahir B, Balachandran K, Bezecny P, Britton F, DeSouza K, Hills D, Moe M, Pigott T, Proctor A , Shah Y et al (2021) . Annals of Oncology, 32(Supplement 5), S466-S466.
  • Lee R, Wysocki O, Zhou C, Calles A, Eastlake L, Ganatra S, Harrison M, Horsley L, Huddar P, Khan K , Mckenzie H et al (2021) . Journal of Clinical Oncology, 39(15_suppl), 1505-1505.
  • Canuas-Landero V, George C, Lefley D, Wilson C & Ottewell P (2021) . Bone Reports, 14.
  • Lee RJ, Wysocki O, Bhogal T, Shotton R, Tivey A, Angelakas A, Aung T, Banfill K, Baxter M, Boyce H , Brearton G et al (2021) . ESMO Open, 6(2), 100056-100056.
  • George C, Lefley D, Canuas-Landero V, Tulotta C, Corness H, Wilson C, Muthana M & Ottewell P (2021) . Bone Reports, 14, 101024-101024.
  • Winter M, Kendall J, Brown S, Rathbone E, Wilson C, Howell S, Twelves C, Palmieri C, Anand A, MacPherson I , Coleman R et al (2021) . Cancer Research, 81(4_Supplement).
  • Pickering K, Wane S, Speake H, Crank H, Anderson A, Cain H, Copeland R, Lee D, Gray J, McNally R , Hargreaves J et al (2021) . Cancer Research, 81(4_Supplement).
  • Badri SE, Hills D, Synowiec A, Harper-Wynne C, Moe M & Wilson C (2021) . Cancer Research, 81(4_Supplement).
  • Lee RJ, Wysocki O, Bhogal T, Shotton R, Tivey A, Angelakas A, Aung T, Banfill K, Baxter M, Boyce H , Brearton G et al (2021) . ESMO Open, 6(1).
  • George CN, Canuas-Landero V, Theodoulou E, Muthana M, Wilson C & Ottewell P (2020) . Journal of Bone Oncology, 25.
  • Lee R, Zhou C, Shotton R, Tivey A, Dickens E, Huddar P, McKenzie H, Boyce H, Maynard A, Rowe MP , Khan S et al (2020) . Annals of Oncology, 31, S999-S999.
  • Baron-Hay S, Theodoulou E, Porter I, Wilson C, Holen I, Harper-Wynne C & Brown J (2020) Abstract P2-18-08: Inclusion of adjuvant bone-modifying agents for early breast cancer into standard clinical practice: Challenges and lessons learnt from an international collaboration. Abstracts: 2019 San Antonio Breast Cancer Symposium.
  • Saleh L, Wilson C & Holen I (2020) . Acta Oncologica, 59(2), 219-232.
  • Ottewell P & Wilson C (2019) . Breast Cancer: Basic and Clinical Research, 13.
  • Wilson C, Martin C & Winter MC (2019) . Journal of Bone Oncology, 15, 100226-100226.
  • Coleman RE, Collinson M, Gregory W, Marshall H, Bell R, Dodwell D, Keane M, Gil M, Barrett-Lee P, Ritchie D , Bowman A et al (2018) . JOURNAL OF BONE ONCOLOGY, 13, 123-135.
  • Wilson C, Bell R, Hinsley S, Marshall H, Brown J, Cameron D, Dodwell D & Coleman R (2018) . European Journal of Cancer, 94, 70-78.
  • Eslamian G, Wilson C & Young RJ (2017) . ONCOTARGETS AND THERAPY, 10, 773-779.
  • Wilson C, Hinsley S, Marshall H, Cameron D, Bell R, Dodwell D & Coleman RE (2017) . Journal of Bone Oncology, 9, 48-54.
  • Wilson C, Brown H & Holen I (2016) . Endocrine-Related Cancer, 23, R567-R576.
  • Wilson C (2016) . Journal of Bone Oncology, 5(3), 139-142.
  • Wilson C & Coleman R (2016) . JAMA Oncology, 2(4), 423-423.
  • Wilson C, Gossiel F, Leonard R, Anderson RA, Adamson DJA, Thomas G & Coleman RE (2016) . Journal of Bone Oncology, 5(1), 43-49.
  • Hadji P, Coleman RE, Wilson C, Powles TJ, Clézardin P, Aapro M, Costa L, Body J-J, Markopoulos C, Santini D , Diel I et al (2016) . Annals of Oncology, 27(3), 379-390.
  • Silva SC, Wilson C & Woll PJ (2015) . Therapeutic Advances in Medical Oncology, 7(4), 219-228.
  • Wilson C, Ottewell P, Coleman RE & Holen I (2015) . BMC Cancer, 15.
  • Coleman R, Cameron D, Dodwell D, Bell R, Wilson C, Rathbone E, Keane M, Gil M, Burkinshaw R, Grieve R , Barrett-Lee P et al (2014) . The Lancet Oncology, 15(9), 997-1006.
  • Brown JE, Zeng L & Wilson C (2014) , 95-124.
  • Wilson C, Khan M & Hancock BW (2013) . Expert Opinion on Orphan Drugs, 1(11), 877-890.
  • Coleman RE, Gregory W, Marshall H, Wilson C & Holen I (2013) . The Breast, 22(Sup 2), S50-S56.
  • Winter MC, Wilson C, Syddall SP, Cross SS, Evans A, Ingram CE, Jolley IJ, Hatton MQ, Freeman JV, Mori S , Holen I et al (2013) . Clinical Cancer Research, 19(10), 2755-2765.
  • Coleman RE, Rathbone EJ, Marshall HC, Wilson C, Brown JE, Gossiel F, Gregory WM, Cameron D & Bell R (2012) . Cancer Research, 72(24_Supplement).
  • Wilson C, Winter MC, Holen I, Freeman JV, Evans AC & Coleman RE (2012) . Cancer Research, 72(24_Supplement).
  • Wilson C, Holen I & Coleman RE (2012) . Cancer Treatment Reviews, 38(7), 877-889.
  • Wilson C & Coleman RE (2011) . Current Opinion in Supportive & Palliative Care, 5(3), 241-250.
  • Woll PJ, Wilson C, Leaning D, Shankland K, Langhenreich T & Batty R (2010) . Journal of Medical Case Reports, 1, 47-50.
  • Wilson C, Nutter F, Brown H, Coleman R & Holen I () . Bone Abstracts.
  • wilson () . Lung Cancer: Targets and Therapy, 37-37.

Book chapters

  • Wilson C, Taylor F & Coleman R (2018) , Side Effects of Medical Cancer Therapy (pp. 439-460). Springer International Publishing
  • Wilson C, Taylor FG & Coleman RE (2013) , Side Effects of Medical Cancer Therapy (pp. 531-567). Springer London
  • Wilson C & Hancock BW (2009) The role of human chorionic gonadotropin (HCG) in gestational trophoblastic disease, Pregnancy Protein Research (pp. 135-147).

Conference proceedings

  • El Badri S, Hills D, Synowiec A, Harper-Wynne C, Moe M & Wilson C (2021) Tolerability and efficacy of palbociclib in combination with an aromatase inhibitor (AI) in older women (≥75 years) with ER +ve, HER2-ve metastatic breast cancer. A large 'real world' UK multi-centre study. CANCER RESEARCH, Vol. 81(4)
  • Pickering K, Wane S, Speake H, Crank H, Anderson A, Cain H, Copeland R, Lee D, Gray J, McNally R , Hargreaves J et al (2021) The new normal; adjusting to remote ways of providing bespoke weight management support to breast cancer survivors during the COVID-19 global pandemic. CANCER RESEARCH, Vol. 81(4)
  • Winter M, Kendall J, Brown S, Rathbone E, Wilson C, Howell S, Twelves C, Palmieri C, Anand A, MacPherson I , Coleman R et al (2021) A randomised phase IB/IIA study of CApecitabine plus Radium-223 in breast cancer patients with BONe metastases (CARBON) - Safety and preliminary efficacy findings. CANCER RESEARCH, Vol. 81(4)
  • Baron-Hay S, Theodoulou E, Porter I, Wilson C, Holen I, Harper-Wynne C & Brown J (2020) . Cancer Research, Vol. 80(4_Supplement)
  • Saleh L, Ottewell PD, Brown JE, Wood SL, Brown NJ, Wilson C, Park C & Holen I (2020) Preventing the progression of breast cancer bone metastasis by CDK inhibition. BREAST CANCER RESEARCH AND TREATMENT, Vol. 180(2) (pp 537-538)
  • Ghazi S, Monawer Karim S, Wilson C & Martin C (2018) . Clinical Oncology, Vol. 30(6) (pp e44-e44)
  • Wilson C, Taylor F & Woll PJ (2010) . Lung Cancer, Vol. 67 (pp S5-S6)